ESC 365 - Low level transcutaneous vagus nerve stimulation reverses cardiac dysfunction and changes left ventricular gene expression in a rat model of heart failure with preserved ejection fraction

ESC Premium Access

Low level transcutaneous vagus nerve stimulation reverses cardiac dysfunction and changes left ventricular gene expression in a rat model of heart failure with preserved ejection fraction

Session: Novel therapies for heart failure in the early pipeline

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor M. Niewiadomska (Oklahoma City, US)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Monika Niewiadomska

University of Oklahoma Health Sciences Center, Oklahoma City (United States of America)

1 follower

2 more presentations in this session

Empagliflozin improves prognosis and energetic properties through modulating mitochondrial function in failing murine hearts

Speaker: Professor A. Shiraki (Saga, JP)

Therapeutic role of Prostaglandin E2 receptor 4 stimulation in inflammatory cardiomyopathy

Speaker: Doctor T. Akira (Yokohama, JP)

Access the full session

Novel therapies for heart failure in the early pipeline

Speakers: Doctor M. Niewiadomska, Professor A. Shiraki, Doctor T. Akira

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources